EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients

Lorena de Mena, Guillem Parés, Alicia Garrido, Daniel F Pilco-Janeta, Manel Fernández, Jesica Pérez, Eduardo Tolosa iD, Ana Cámara, Francesc Valldeoriola, Mario Ezquerra, María-José Martí, Rubén Fernández-Santiago iD und 1 weitere

Movement Disorders · 2025-03 · 40 (3) · 550-555

DOI: 10.1002/mds.30094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 23.12.2024. Verfasst von Lorena de Mena und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Parkinson's and Other Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, DNA Methylation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) co-funded by the European Union, Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Miguel Servet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background α‐Synuclein ( SNCA ) gene hypomethylation was reported in idiopathic Parkinson's disease (iPD). Based on a high clinical resemblance between iPD and leucine‐rich repeat kinase 2 (LRRK2)‐driven Parkinson's disease (L2PD), we investigated the epigenetic status of SNCA in an extensive LRRK2 clinical cohort from Spain.

Methods

We assessed the methylation levels of 23 CpG sites in the SNCA promoter region using peripheral blood DNA from L2PD patients (n = 151), LRRK2 nonmanifesting carriers (n = 55), iPD patients (n = 115), and healthy control subjects (n = 154) (total: N = 475).

Results

Compared with control subjects, we found significant SNCA hypomethylation in 11 of 23 CpGs in L2PD (48%), whereas 22 CpGs (96%) were hypomethylated in iPD. In line with a healthy status, asymptomatic mutation carriers had similar SNCA methylation profiles to control subjects.

Conclusions

This study shows for the first time that SNCA hypomethylation occurs in patients with L2PD. Further studies addressing SNCA methylation status in additional worldwide LRRK2 cohorts are warranted. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2DNA MethylationHumansMaleFemaleMiddle AgedAgedMutationCpG IslandsPromoter Regions, GeneticSpainAdult

Stichwörter der Autor:innen

LRRK2Parkinson'sSNCAepigeneticsleucine‐rich repeat kinase 2promoterα‐Synuclein

Substanzen

alpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanSNCA protein, human

Autor:innen und Institutionen

  • Laboratory of Parkinson's and Other Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas CB06/05/0018-ISCIII, Barcelona, Spain.

ORCID-Profile: Eduardo Tolosa, Rubén Fernández-Santiago

Förderung

  • Instituto de Salud Carlos III (ISCIII) co-funded by the European Union
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)
  • Miguel Servet
  • Instituto de Salud Carlos III

Zitieren

APA

de Mena, L., Parés, G., Garrido, A., Pilco-Janeta, D. F., Fernández, M., Pérez, J., Tolosa, E., Cámara, A., Valldeoriola, F., Ezquerra, M., Martí, M. J., Fernández-Santiago, R., & Barcelona LRRK2 Study Group (2025). α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients. Movement Disorders, 40(3), 550-555. https://doi.org/10.1002/mds.30094

Vancouver

de Mena L, Parés G, Garrido A, Pilco-Janeta DF, Fernández M, Pérez J, et al. α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients. Movement Disorders. 2025;40(3):550-555. doi:10.1002/mds.30094

BibTeX
@article{deMena2025,
  author = {de Mena, Lorena and Parés, Guillem and Garrido, Alicia and Pilco-Janeta, Daniel F and Fernández, Manel and Pérez, Jesica and Tolosa, Eduardo and Cámara, Ana and Valldeoriola, Francesc and Ezquerra, Mario and Martí, María-José and Fernández-Santiago, Rubén and Barcelona LRRK2 Study Group, Barcelona LRRK2 Study Group},
  title = {α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {3},
  pages = {550--555},
  doi = {10.1002/mds.30094}
}
Kostenlos starten →